Isorhamnetin ameliorates cisplatin-induced acute kidney injury in mice by activating SLPI-mediated anti-inflammatory effect in macrophage.
Jia JianLi Yu-QingHan Rang-YueZhong XiaXie Ke-HuanYan YingWang LiTan Rui-ZhiPublished in: Immunopharmacology and immunotoxicology (2024)
Isorhamnetin inhibits macrophage inflammation and protects kidney in AKI may be related to downregulating Mincle/Syk/NF-κB-maintained macrophage phenotype by activating SLPI.